key: cord-0891245-1kz3edmy authors: Kumar, Swatantra; van Regenmortel, Marc H.V.; Rivas, Ariel L.; Saxena, Shailendra K title: Structural and molecular perspectives of SARS-CoV-2 date: 2021-03-15 journal: Methods DOI: 10.1016/j.ymeth.2021.03.007 sha: 20e4940c6494019b4f5e6e0b9b50de71f7dfb339 doc_id: 891245 cord_uid: 1kz3edmy Recent emergence of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transpired into pandemic coronavirus disease 2019 (COVID-19). SARS-CoV-2 has been rapidly transmitted across the globe within a short period of time, with more than 106 million cases and 2.3 million deaths. The continuous rise in worldwide cases of COVID-19, transmission dynamics of SARS-CoV-2 including re-infections and enormous case-fatality rates emphasizes the urgent need of potential preventive and therapeutic measures. The development of effective therapeutic and preventive measures relies on understanding the molecular and cellular mechanism of replication exhibited by SARS-CoV-2. The structure of SARS-CoV-2 is ranging from 90/120 nm that comprises surface viral proteins including spike, envelope, membrane which are attached in host lipid bilayer containing the helical nucleocapsid comprising viral RNA. Spike (S) glycoprotein initiates the attachment of SARS-CoV-2 with a widely expressed cellular receptor angiotensin-converting enzyme 2 (ACE2), and subsequent S glycoprotein priming via serine protease TMPRSS2. Prominently, comprehensive analysis of structural insights into the crucial SARS-CoV-2 proteins may lead us to design effective therapeutics molecules. In the present article, we will emphasize the mechanistic insights of SARS-CoV-2 replication including insights into the structural perspective of crucial SARS-CoV-2 proteins.  Spike glycoprotein undergoes two conformational states i.e. receptor-inaccessible state and receptor-accessible state upon binding to ACE2.  S1 subunit involved in the attachment to the peptidase domain (PD) of the ACE2 receptor via RBD and S2 subunit involved in cell and viral membrane fusion.  SARS-CoV-2 and SARS-CoV RBDs use eight identical interacting residues for attachment to the ACE2 receptor.  Main protease (Mpro) doesn't share cleavage sites with any human encoded proteases; therefore, it can be one of the best drug targets for combating CoVs. Unprecedented global emergence of novel coronavirus (nCoV) coined as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2019 in Wuhan, China has led the whole world susceptible towards its infection causing a pandemic Coronavirus disease 2019 (COVID-19) [1] . According to the World Health Organization (WHO), SARS-CoV-2 has infected at least 106 million people worldwide with 2.3 million deaths affecting at least 220 countries, areas and territories [2] . The uninterrupted rise in worldwide cases of COVID-19, transmission dynamics of SARS-CoV-2 including re-infections and enormous case-fatality rates emphasizes the urgent need of effective therapeutic and preventive measures [3] . Coronaviruses (CoVs) are a family of positive sense enveloped RNA viruses known to infect a wide range of species including avian, humans, livestock and companion animals. Until 2019, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) were the only two known CoVs which causes a severe respiratory illness in humans [4] . SARS-CoV-2 is the 7 th CoV which is known to infect human where SARS-CoV and MERS-CoV, SARS-CoV-2 infection results in severe disease and HKU1, OC43, NL63 and 229E were found to cause mild symptoms [5] . Human transmission of SARS-CoV-2 is primarily exhibited via direct, indirect or close contact with infected secretions including respiratory droplets, saliva generated when an infected individual coughs, sneezes, talks or sings [6] . However, other routes of transmission occur via fomite, blood borne, fecal-oral, mother-to-child, and animal-to-human transmission [7] . SARS-CoV-2 primarily targets the respiratory systems, however, complication in other systems including cardiovascular, neurological and renal also contributes to the mortality [8] . So far, the clinical characteristics are considerably heterogeneous which ranges from asymptomatic to mild, moderate and severe disease forms [9] . SARS-CoV-2 infection is characterized by various immunopathological features including lymphopenia, lymphocyte activation and dysfunction, increased level of neutrophils, cytokine storm, depletion and exhaustion of lymphocytes [10] . Still lack of specific treatment for COVID-19 is the major cause of mortality since the treatment mainly depends on supportive care of the patients. Interestingly, a number of therapeutic molecules including repurposed drugs are found efficient for the treatment of COVID-19 [11, 12 and 13] . Although a large number of studies and clinical trials are being performed [14, 15] , a comprehensive understanding of SARS-CoV-2 structure and replication is decisive for designing effective preventive and therapeutic measures. Vero cells infected with SARS-CoV-2 subjected to transmission electron microscopy using ultrathin sections have allowed a morphological understanding of the structure of SARS-CoV-2. The tomograms generated by electron microscopy revealed that SARS-CoV-2 is of oval shape. Spike glycoprotein (S-glycoprotein) is a trimeric fusion protein of class I type that exists in a metastable prefusion conformation of club-like shape of ~20 nm in length ( Figure 3A ) [24] . S-glycoprotein mediates the attachment and entry into the host cells through widely expressed cellular receptor angiotensin-converting enzyme 2 (ACE2) [25] . S-glycoprotein consists of two functional subunits S1 and S2 where S1 subunit comprises the N-terminal domain (NTD), signal sequence and receptor binding domain (RBD) whereas, S2 subunit is involved consists of heptadrepeat (HR) regions as HR-N and HR-C crucial for the generation of coiled coil structure inside the protein ectodomain [25, 26] . Several of the cleavage sites including furin, protease and S2′ protease are present at the border of S1 and S2 [27] . The S1 subunit involve in the in the attachment to the peptidase domain (PD) of the ACE2 receptor via RBD and S2 subunit involved in the cell and viral membrane fusion. The processing of S-glycoprotein occurs at the boundary of S1 and S2 subunits that is non-covalently associated in prefusion conformation [24] . The ectodomain consists of a head which is connected to the membrane a slender stalk [28] . The three RBDs are conformationally variable which are shielded by the N-terminal domains (NTDs). Upon binding to the ACE2 receptor, the RBD undergoes hinge-like conformational arrangements that temporarily exposes or hide the binding receptors [29] . These two states are denoted as down i.e. receptor-inaccessible state or up conformation i.e. receptor-accessible state [30] . The interaction between RBD and ACE2 receptor was found to be similar to the polar Interestingly, structure-guided sequence alignment has revealed that SARS-CoV-2 and SARS-CoV RBDs use eight identical interacting residues for attachment to the ACE2 receptor. The Mpro acts on at least 11 Leu-Gln ↓ (Ser, Ala, Gly) cleavage sites present on the pp1ab (↓ marks the cleavage site) [35] . Interestingly, Mpro doesn't share these cleave sites with any human encodes proteases, with the result that Mpro has been found as one of the best-characterized drug targets for combating CoVs [36] . The structure of SARS-CoV-2 Mpro was found to be similar as SARS-CoV Mpro due to 96% sequence identity and was found to structurally diverge by only 0.53 Å. Mpro is characterized as six-stranded antiparallel β barrels which exhibit the substratebinding site. The structure of Mpro resembles that of chymotrypsin (residues 10 to 99) as well as picorna 3 C protease-like domains = I and II (residues 100 to 182). Whereas, the domain III (residues 198 to 303) forms five helices of globular shape which involve in the dimerization of Mpro exhibited via salt bridge interaction among Arg 4 of one protomer with Glu 290 residue of the other ( Figure 3C) [37]. Dimerization of Mpro has been shown to be crucial for its catalytic activity due to NH2-terminal residues (N-finger) of all protomers interacting with Glu 166 required for substrate specific binding site, S1 pocket of the enzyme. The nucleocapsid (N) protein of coronavirus is a multi-faceted RNA-binding protein crucial for replication and transcription of SARS-CoV-2 [38] . The primary role of N protein is binds to SARS-CoV-2 RNA and form the ribonucleoprotein (RNP) complex. Crystal structure of 47-173 residues of N protein of SARS-CoV-2 revealed that SARS-CoV-2 N-NTD packed into an orthorhombic crystal form while the interaction between the interfaces occurs via residues of βhairpin fingers and palm regions. The core of the protein is made up of five antiparallel β-strands where a single short helix exists just ahead of β2 strand and protruding β-hairpin between strands β2 and β5 ( Figure 3D ) [39] . Among the nsps, nsp10 and nsp 16 have been shown to form a protein complex that requires for methylation at ribose 2′-O position of intermediate nucleotide of SARS-CoV-2 RNA cap [40] . This methylation is crucial for the conversion of cap-0 to cap-1 viral RNA to mimic the cellular mRNAs for translation and a host defense mechanism. The crystal structure of the protein complex was solved at 2.5 Å resolutions. The two complex proteins were found similar to a RMSD of ~ 0.2Å. Altogether, the nsp10/nsp16 2′-O-methylase was found as nsp16 monomer sitting on top of nsp10 monomer where the nsp16 is consists of seven α-helices, twelve β-strands and five 310 helices. These secondary structures assemble together to form a core comprised of helices αZ, αA, αD, and αE and strands β1-β7. Whereas, bottom of the nsp10 consists of three α-helices, three β-strands and two 310 helices where two zinc-fingers have been found to stabilizes the structure ( Figure 3E ). Within the heterodimer complex, nsp10 is crucial due to its role as a co-factor for nsp16 methylase [41] . Although, some studies and clinical trials have been performed with SARS-CoV-2, further studies are still required for designing effective preventive and therapeutic measures. The SARS-CoV-2 and SARS-CoV are not only phylogenetically related but are morphologically similar. Among the structural proteins, the spike which is a trimeric glycoprotein has only been studied extensively for a short period of time although it is essential for the attachment to the cellular receptor ACE2. In addition to spike, several of the proteins including Mpro, nucleocapsid protein RNA binding domain and nsp10/nsp16 2′-O-methylase are crucial targets for developing antiviral drugs. The continuous rise in the COVID-19 cases and its severity emphasizes the urgent need of The authors are grateful to the Vice Chancellor, King George's Medical University (KGMU), Lucknow, India for the encouragement for this work. SKS conceived the idea. S.K. and S.K.S. collected the data, devised the initial draft and All authors read and approved the final version of the manuscript. The authors declare no competing financial interest. The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. We have not received any specific funding for this work. for structural proteins as well as seven putative ORFs interspersed between the structural genes and encodes for accessory proteins. The replicase gene covers 67% of the 5′ genome which encodes for a large polyprotein (pp1ab) that gets proteolytically processed into 16 non-structural proteins (nsps). SARS-CoV-2 has surface structural proteins, namely, spike glycoprotein (S), viral membrane glycoprotein (M) and envelope (E) of which are embedded in host membrane-derived lipid bilayer encapsulating the helical nucleocapsid viral RNA. A novel coronavirus outbreak of global health concern Coronavirus disease (COVID-19) pandemic. World Health Organization (WHO) Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases Origin and evolution of pathogenic coronaviruses The proximal origin of SARS-CoV-2 Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period Transmission of SARS-CoV-2: implications for infection prevention precautions. World Health Organization (WHO) room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infectionprevention-precautions Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. The Lancet. Respiratory medicine Physiological and biological heterogeneity in COVID-19-associated acute respiratory distress syndrome. The Lancet. Respiratory medicine COVID-19: immunopathogenesis and Immunotherapeutics. Signal transduction and targeted therapy Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection Structurebased drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor Recombinant vaccines for COVID-19 Ongoing Clinical Trials for the Management of the COVID-19 Pandemic Structure-based design of prefusion-stabilized SARS-CoV-2 spikes Chasing COVID-19 through SARS-CoV-2 spike glycoprotein Advance online publication Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 Proteolytic Cleavage of the SARS-CoV Spike Protein and the Role of the Novel S1/S2 Site. SSRN, 3581359 In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges Critical Differences between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV. The journal of physical chemistry The coronavirus nucleocapsid protein is dynamically associated with the replication-transcription complexes Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin